|

Liver Cancer Clinical Trials in New Jersey

18 recruiting studies across 12 cities

All Trials in New Jersey

Phase
Trial Phase Location
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors—Basking Ridge
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal CancerPhase 2Basking Ridge
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)Phase 2Basking Ridge
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical CarcinomaPhase 2Basking Ridge
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialPhase 3Basking Ridge
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsPhase 1East Brunswick
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid TumorsPhase 1East Brunswick
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT—Egg Harbor
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial HepatectomyN/AEnglewood
A Study of ZW251 in Participants With Advanced Solid TumorsPhase 1Hackensack
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)Phase 1/2Hackensack
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid TumoursPhase 1/2Hackensack
A Study of Methylprednisolone in People Having Liver SurgeryPhase 3New Brunswick
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular CarcinomaPhase 3New Brunswick
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry—New Brunswick
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular CarcinomaPhase 2New Brunswick
Liver Transplantation in Intrahepatic Cholangiocarcinoma—Newark
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsPhase 2Summit

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.